Bali Pulendran | Professor, Department Of Pathology, Microbiology And Immunology
Stanford University School of Medicine (USA)

Bali Pulendran, Professor, Department Of Pathology, Microbiology And Immunology, Stanford University School of Medicine (USA)

Professor Bali Pulendran is the Violetta L. Horton Professor at the Stanford University School of Medicine, and a member of the Institute for Immunology, Transplantation and Infection, and the Departments of Pathology and Microbiology & Immunology at Stanford University. He is also an adjunct professor at the Yerkes National Primate Center at Emory University, and director of the NIH U19 Center for Systems Vaccinology, at Emory University in Atlanta. He received his undergraduate degree from Cambridge University, and his Ph.D from the Walter & Eliza Hall Institute in Melbourne, Australia, under the supervision of Sir Gustav Nossal. He then did his post-doctoral work at Immunex Corporation in Seattle. Dr. Pulendran is a world leader on understanding the mechanisms by which the innate immune system regulates adaptive immunity and harnessing such mechanisms in the design of novel vaccines. More recently, his laboratory pioneered the use of systems biological approaches to predicting the efficacy of vaccines, and deciphering new correlates of protection against infectious diseases. Dr. Pulendran?s research is published in front line journals such as Nature, Science, Cell, Nature Medicine, and Nature Immunology. Furthermore, Dr. Pulendran is the recipient of numerous grants from the National Institutes of Health, and from The Bill and Melinda Gates Foundation, serves on many editorial boards, and is the recipient of two concurrent MERIT awards from the National Institutes of Health, as well as the 2011 Albert. E. Levy Award, 2011 Paper of the year award by the International Society for Vaccines.


WVIC/WAC Day 1 - Nov 29 @ 10:00

Defining immune health and its implications for ID & Cancer

  • How do we define immune fitness / immune health – progress towards human immunome
  • How are we studying this at a systems level? How do vaccines positively impact immune fitness?
  • Defining tumor archetypes – what common immunological features contribute to better response rates
last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

For sponsorship and exhibition opportunities:
Thomas Hall